Tumour microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer
A Semeniuk-Wojtaś, K Poddębniak-Strama… - Cancer Immunology …, 2023 - Springer
Bladder cancer (BC) can be divided into two subgroups depending on invasion of the
muscular layer: non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder …
muscular layer: non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder …
[HTML][HTML] Immune escape mechanisms and immunotherapy of urothelial bladder cancer
Z Yang, Y Xu, Y Bi, N Zhang, H Wang… - Journal of clinical and …, 2021 - ncbi.nlm.nih.gov
Methods: Based on a comprehensive search of the PubMed and ClinicalTrials. gov
database, this review included the literature reporting the immune escape mechanisms of …
database, this review included the literature reporting the immune escape mechanisms of …
Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells
M Ferreira-Teixeira, D Paiva-Oliveira, B Parada… - BMC medicine, 2016 - Springer
Background High-grade non-muscle invasive bladder cancer (NMIBC) has a high risk of
recurrence and progression to muscle-invasive forms, which seems to be largely related to …
recurrence and progression to muscle-invasive forms, which seems to be largely related to …
Comprehensive analyses of a tumor-infiltrating lymphocytes-related gene signature regarding the prognosis and immunologic features for immunotherapy in bladder …
Z He, J Gu, T Luan, H Li, C Li, Z Chen, E Luo… - Frontiers in …, 2022 - frontiersin.org
Tumor-infiltrating lymphocyte (TIL) is a class of cells with important immune functions and
plays a crucial role in bladder cancer (BCa). Several studies have shown the clinical …
plays a crucial role in bladder cancer (BCa). Several studies have shown the clinical …
Re-expression of poly/oligo-sialylated adhesion molecules on the surface of tumor cells disrupts their interaction with immune-effector cells and contributes to …
M Jarahian, F Marofi, MS Maashi, M Ghaebi, A Khezri… - Cancers, 2021 - mdpi.com
Simple Summary The immune system consists of various mechanisms contributing to the
battle against cancer cells or hazardous pathogens. However, in cancer progression the …
battle against cancer cells or hazardous pathogens. However, in cancer progression the …
[HTML][HTML] Effects of PHA-665752 and vemurafenib combination treatment on in vitro and murine xenograft growth of human colorectal cancer cells with BRAFV600E …
J Zhi, Z Li, J Lv, B Feng, D Yang, L Xue… - Oncology …, 2018 - spandidos-publications.com
It remains unknown whether blockade of B-Raf proto-oncogene, serine/threonine kinase
(BRAF) V600E signaling and MET proto-oncogene, receptor tyrosine kinase (c‑Met) …
(BRAF) V600E signaling and MET proto-oncogene, receptor tyrosine kinase (c‑Met) …
Spatial Distribution of Macrophage and Lymphocyte Subtypes within Tumor Microenvironment to Predict Recurrence of Non-Muscle-Invasive Papillary Urothelial …
J Drachneris, M Morkunas, M Fabijonavicius… - International Journal of …, 2024 - mdpi.com
Non-muscle-invasive papillary urothelial carcinoma (NMIPUC) of the urinary bladder is the
most common type of bladder cancer. Intravesical Bacille Calmette–Guerin (BCG) …
most common type of bladder cancer. Intravesical Bacille Calmette–Guerin (BCG) …
Cell Surface Engineering to Improve Migration of Natural Killer Cells Toward Bladder Cancer
J Silang, Z Cai, G Liu, B Zhang - Journal of Biomaterials and …, 2022 - ingentaconnect.com
Natural killer (NK) cells therapy for bladder cancer has shown a promise in clinical studies.
However, insufficient of NK cells to the bladder cancer represents an important reason for …
However, insufficient of NK cells to the bladder cancer represents an important reason for …